Resolve BioSciences
Latest round
- Series B
Last raised
- Aug 2022
Total raised
- $95M
Investors
- 9
About Resolve BioSciences
Resolve BioSciences GmbH, founded in 2012 in Germany, focuses on advanced spatial analysis solutions for the life sciences sector. The founders, Axel Heinemann and Peer Schatz, pioneered efforts in spatial analysis technologies.Resolve Biosciences specializes in innovative spatial analysis technology through its flagship product, the Molecular Cartography platform. This platform is designed to tackle complex biological challenges in fields such as oncology, neuroscience, and infectious disease. It enables scientists to achieve highly multiplexed spatial analysis, producing comprehensive data sets that elucidate molecular interactions at subcellular resolution while preserving tissue integrity. Initial applications focus on providing high-resolution insights into transcriptomic activity, allowing for the interrogation of hundreds of genes in one run.Resolve Biosciences generates revenue through the provision of its Molecular Cartography platform and related services, typically offered under a subscription model or direct service agreements with clients in the life sciences sector. Clients, including academic research institutions and commercial laboratories, utilize the platform for advanced research in various biomedical fields. The company plans to expand its product offerings and may target new geographic markets, although specific new regions have not been disclosed.
Who invested in Resolve BioSciences
9 investors across 2 rounds
See all investors in Resolve BioSciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Resolve BioSciences
Who invested in Resolve BioSciences?
Resolve BioSciences has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Resolve BioSciences raised?
Resolve BioSciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Resolve BioSciences last raise money?
Resolve BioSciences's most recent round on record is a Series B, in Aug 2022.
What does Resolve BioSciences do?
Resolve BioSciences GmbH, founded in 2012 in Germany, focuses on advanced spatial analysis solutions for the life sciences sector.
Where is Resolve BioSciences headquartered?
Resolve BioSciences is headquartered in Germany.
Which VCs invest in companies like Resolve BioSciences?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Resolve BioSciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Resolve BioSciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.